Publications by authors named "Jose Adélaide"

76Publications

Gains of EPOR and ERG genes in adult erythroleukaemia.

Br J Haematol 2020 05 29;189(4):e174-e177. Epub 2020 Mar 29.

Laboratoire d'Oncologie Prédictive, Centre de Recherche en Cancérologie de Marseille (CRCM), UMR 1068 Inserm, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université UM105, Marseille, France.

View Article and Find Full Text PDF
May 2020

EBV+ diffuse large B-cell lymphoma associated with chronic inflammation expands the spectrum of breast implant-related lymphomas.

Blood 2020 May;135(22):2004-2009

Department of Biopathology and Tumor Immunology, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique UMR 7258, Aix-Marseille University, UM105, Marseille, France.

View Article and Find Full Text PDF
May 2020

Acute erythroid leukemias have a distinct molecular hierarchy from non-erythroid acute myeloid leukemias.

Haematologica 2020 Jul 10;105(7):e340-e342. Epub 2019 Oct 10.

Laboratoire d'Oncologie Prédictive, Centre de Recherche en Cancérologie de Marseille UMR1068 Inserm, Institut Paoli-Calmettes, CNRS UMR7258, Aix-Marseille Université UM105, Marseille.

View Article and Find Full Text PDF
July 2020

A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers.

Cancers (Basel) 2019 Aug 13;11(8). Epub 2019 Aug 13.

Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Univ, CRCM, CNRS, INSERM, 13000 Marseille, France.

View Article and Find Full Text PDF
August 2019

A Comparison of DNA Mutation and Copy Number Profiles of Primary Breast Cancers and Paired Brain Metastases for Identifying Clinically Relevant Genetic Alterations in Brain Metastases.

Cancers (Basel) 2019 May 13;11(5). Epub 2019 May 13.

Laboratoire d'Oncologie Prédictive, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Aix-Marseille Université, Institut Paoli-Calmettes, F-13009 Marseille, France.

View Article and Find Full Text PDF
May 2019

Mutation patterns in essential thrombocythemia, polycythemia vera and secondary myelofibrosis.

Leuk Lymphoma 2019 05 2;60(5):1289-1293. Epub 2019 Jan 2.

a Laboratoire d'Oncologie Prédictive , Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille , Inserm U1068 CNRS UMR 7258 , Marseille , France.

View Article and Find Full Text PDF
May 2019

Epigenetically centered evolution in an example of myeloid malignancy.

Am J Hematol 2016 09 4;91(9):E361-2. Epub 2016 Jul 4.

Centre de Recherche en Cancérologie de Marseille, Laboratoire D'Oncologie Moléculaire, UMR1068 Inserm, Institut Paoli-Calmettes, CNRS UMR725, Marseille, France.

View Article and Find Full Text PDF
September 2016

Expression of Genes with Copy Number Alterations and Survival of Patients with Pancreatic Adenocarcinoma.

Cancer Genomics Proteomics 2016 May-Jun;13(3):191-200

Department of Molecular Oncology UMR1068, Paoli-Calmettes Instituet, Marseille, France Aix-Marseille University, Marseille, France.

View Article and Find Full Text PDF
January 2017

Comparative genomic analysis of primary tumors and metastases in breast cancer.

Oncotarget 2016 May;7(19):27208-19

Département d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Marseille, France.

View Article and Find Full Text PDF
May 2016

Prognostic and predictive value of PDL1 expression in breast cancer.

Oncotarget 2015 Mar;6(7):5449-64

Département d'Oncologie Moléculaire, "Equipe labellisée Ligue Contre le Cancer", Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Marseille, France.

View Article and Find Full Text PDF
March 2015

Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization.

Mol Cancer 2014 Oct 2;13:228. Epub 2014 Oct 2.

Department of Molecular Oncology, Centre de Recherche en Cancérologie de Marseille, UMR1068 Inserm, Institut Paoli-Calmettes (IPC), Marseille, France.

View Article and Find Full Text PDF
October 2014

ESPL1 is a candidate oncogene of luminal B breast cancers.

Breast Cancer Res Treat 2014 Aug 3;147(1):51-9. Epub 2014 Aug 3.

Department of Molecular Oncology, U1068 Inserm, Institut Paoli-Calmettes (IPC), Marseille, France.

View Article and Find Full Text PDF
August 2014